Skip to content

Capnia CAPN Debt Instrument Convertible Conversion Price

Debt Instrument Convertible Conversion Price at other companies

XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$1,000.00
NextNRG, Inc. Common Stock logo
NextNRG, Inc. Common StockNXXT
$0.00
Envoy Medical logo
Envoy MedicalCOCH
$11.500.0%
Kopin logo
KopinKOPN
$4.40
Finance of America Companies logo
Finance of America CompaniesFOA
$35.00
BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
$6.02

Other financials

Income statement

See full
Operating income-$294.2K-24.8%
Net income$252.4K-37.6%
EPS (diluted)$0.03-40.0%

Balance sheet

See full
Cash & equivalents$64.4K+1.2%
Total equity-$3.5M-94.6%
Total assets$37.7M-39.0%

Cash flow

See full
Operating cash flow$763.0+101%

Valuation

See full
Market cap$58.49M-27.6%
P/E39.4×-26.2×

Returns & leverage

See full
Return on equity-56.8%
Current ratio0.1×-2.7×

Where this comes from

Reported directly by Capnia in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentConvertibleConversionPrice1.

The official record: Capnia’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capnia's debt instrument convertible conversion price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capnia's debt instrument convertible conversion price?
Capnia (CAPN) reported debt instrument convertible conversion price of $10.00 in Q1 2026.
How has Capnia's debt instrument convertible conversion price changed year-over-year?
Capnia's debt instrument convertible conversion price decreased by 0.0% year-over-year, from $10.00 to $10.00.
What does debt instrument convertible conversion price mean?
The predetermined price at which holders of convertible debt instruments may exchange their debt for shares of the company's common stock. This value is essential for calculating potential dilution and understanding the incentive structure for debt holders. It serves as a benchmark for evaluating the cost of capital and future equity issuance.